Full Year 2019 Poxel SA Earnings Call Transcript
Ladies and gentlemen, welcome to the Poxel conference call.
I now hand it over to Jonae Barnes. Madam, please go ahead.
Good afternoon, everyone, and welcome to Poxel's Full Year 2019 Financial Results and Corporate Update Investor Conference Call. I'm Jonae Barnes, Senior Vice President, Investor Relations and Public Relations. With me on the call, Thomas Kuhn, CEO; Anne Renevot, CFO. Also joining us today are David Moller, CSO; Noah Beerman, President of U.S. Operations and EVP of Business Development; Sébastien Bolze, Chief Operating Officer, EVP, Nonclinical and Manufacturing Operations; and Pascale Fouqueray, EVP, Translational Medicine and Early Clinical Development. We will all be available for Q&A after our call is complete.
Earlier today, we issued a press release which included our full year 2019 financial results and a corporate update. For those of you who don't have a copy, you can access it in the Investor Relations section of our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |